ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma
Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia
Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO
Phase II Study Finds Dasatinib May Overcome ALL Resistance
Sarcoma Survivors At Risk Of Blood Clots, Study Finds
Risk of Lymphoma Increases with Hepatitis C Virus Infection
Long-Term Results Find Cisplatin Improves Survival
Study Links Ovarian Cancer To Hormone Replacement
Smokers Who Quit Live Longer Than Those Who Spit-Study
FDA Approves New Drug for Advanced Kidney Cancer
FDA Approves New Indication For Anticoagulant Frangmin
NCI-Approved Group, Center Clinical Trials Listed
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Protecting the cure: Why the future of radiation oncology must be precision-guided
- Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research - NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Wafik El-Deiry steps down as director of Brown’s Legorreta Cancer Center
